Ameriprise’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.14M | Buy |
134,303
+102,888
| +328% | +$871K | ﹤0.01% | 3186 |
|
|
2025
Q1 | $253K | Sell |
31,415
-6,381
| -17% | -$51.3K | ﹤0.01% | 3695 |
|
|
2024
Q4 | $339K | Buy |
37,796
+26,981
| +249% | +$242K | ﹤0.01% | 3652 |
|
|
2024
Q3 | $79.3K | Buy |
10,815
+130
| +1% | +$953 | ﹤0.01% | 3845 |
|
|
2024
Q2 | $61K | Buy |
+10,685
| New | +$61K | ﹤0.01% | 3809 |
|
|
2020
Q1 | – | Sell |
-146,841
| Closed | -$2.98M | – | 3639 |
|
|
2019
Q4 | $2.98M | Sell |
146,841
-212,250
| -59% | -$4.3M | ﹤0.01% | 2525 |
|
|
2019
Q3 | $1.92M | Sell |
359,091
-3,248
| -0.9% | -$17.4K | ﹤0.01% | 2711 |
|
|
2019
Q2 | $2.38M | Sell |
362,339
-3,171
| -0.9% | -$20.9K | ﹤0.01% | 2641 |
|
|
2019
Q1 | $2.38M | Sell |
365,510
-1,696
| -0.5% | -$11K | ﹤0.01% | 2659 |
|
|
2018
Q4 | $2.5M | Sell |
367,206
-2,146
| -0.6% | -$14.6K | ﹤0.01% | 2542 |
|
|
2018
Q3 | $2.45M | Buy |
369,352
+69,360
| +23% | +$460K | ﹤0.01% | 2736 |
|
|
2018
Q2 | $1.69M | Buy |
299,992
+40,138
| +15% | +$226K | ﹤0.01% | 2795 |
|
|
2018
Q1 | $1.35M | Buy |
259,854
+22,501
| +9% | +$117K | ﹤0.01% | 2839 |
|
|
2017
Q4 | $1.08M | Buy |
237,353
+25,784
| +12% | +$117K | ﹤0.01% | 2944 |
|
|
2017
Q3 | $1.33M | Buy |
211,569
+60,101
| +40% | +$377K | ﹤0.01% | 2833 |
|
|
2017
Q2 | $928K | Buy |
+151,468
| New | +$928K | ﹤0.01% | 2972 |
|